Portfolio overview

As at 31 July 2026

10 largest holdings

(% of total investments)

Name

Total

C4 Therapeutics

4.0

Vertex Pharmaceuticals

3.4

Arcutis Biotherapeutics

3.3

Travere Therapeutics

3.0

Biogen

2.8

Palvella Therapeutics

2.8

uniQure

2.7

Praxis Precision Medicines

2.4

Rhythm Pharmaceuticals

2.3

Edgewise Therapeutics

2.3

Total

29.0

Geographic breakdown

(%)

  • North America 86% 86
  • Continental Europe 8.9% 8.9
  • China 3.8% 3.8
  • United Kingdom 0.6% 0.6
  • Taiwan 0.5% 0.5
  • Unquoted ‡ 0.2% 0.2

Return vs volatility

(Annualised since appointment of OrbiMed: May 2005) – Chart (%)

Plot graph showing return vs volatility of Finsbury Growth & Income Trust (price) and FTSE All-Share Index (total return)